For Lilly Pharmaceuticals, an interactive table was developed that recognized 3D molecular models, showcasing drug details at a Rio Congress for rheumatology experts.
Introduction
In the realm of pharmaceutical advancements, it's paramount to offer engaging and interactive experiences that efficiently communicate the complexities of drug structures and their effects. This is particularly important when targeting an audience of specialized doctors, like rheumatologists.
Challenge
Lilly Pharmaceuticals required an impactful method to present their novel molecular creations to a select audience at an International Congress held in Rio de Janeiro. They aimed to go beyond traditional presentation methods and bring their molecules to life, giving the attendees a more immersive understanding of their capabilities.
Solution
While working with Antídoto Design, we developed an interactive table that incorporated advanced object recognition technology. This table, when paired with 3D printed molecular structures, could identify each molecule when placed on it. Beneath each 3D model, a recognition point technology was embedded. Once a molecule was positioned on the table, the system would instantly recognize it, and detailed information about that particular molecule would be displayed. The visual appeal of the 3D representations combined with the dynamic interaction provided by the table ensured that the information was not only accessible but also captivating.
Conclusion
The project was a resounding success, bridging the gap between complex molecular science and the targeted audience of rheumatology specialists. It showcased Lilly Pharmaceuticals' advancements in an innovative manner, ensuring that the message was delivered effectively and memorably. Through this synergy of design and technology, we achieved a breakthrough in interactive pharmaceutical presentations.